Weight Loss Drug: Viking Therapeutics Says Lead Obesity Drug Shows Weight Retention with Less Frequent Dosing

Viking Therapeutics Stock Surges 36%. It Could Challenge Lilly and Novo's Obesity Empire.

Obesity battle heats up again as Novo claws way back into race with Lilly

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot's Side Effects